Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture

Molecular Pharmaceutics

Volumn 6, Issue 5, 2009, Pages 1492-1505

  Rumondor, Alfred C F ^a   Marsac, Patrick J ^a,b   Stanford, Lindsay A ^a   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Amorphous; Crystallization; Miscibility; Moisture; Solid dispersion

Indexed keywords

DROPERIDOL; FELODIPINE; INDOMETACIN; KETOPROFEN; NIFEDIPINE; PIMOZIDE; POVIDONE;

AMORPHOUS SOLID DISPERSION; CONFERENCE PAPER; CRYSTALLIZATION; DISPERSION; GLASS TRANSITION TEMPERATURE; HUMIDITY; HYDROPHILICITY; HYDROPHOBICITY; MISCIBILITY; MOISTURE; PHASE SEPARATION; PRIORITY JOURNAL; ROOM TEMPERATURE; SOLID;

ADSORPTION; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DROPERIDOL; DRUG DELIVERY SYSTEMS; DRUG INTERACTIONS; HUMIDITY; HYDROPHOBICITY; INDOMETHACIN; KETOPROFEN; NIFEDIPINE; PHASE TRANSITION; PIMOZIDE; POVIDONE; SPECTROPHOTOMETRY, INFRARED; WATER;

EID: 70350057599     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp900050c     Document Type: Conference Paper

References (45)

1. Chiou, W. L.; Riegelman, S. Pharmaceutical Applications Of Solid Dispersion Systems. J. Pharm. Sci. 1971, 60 (9), 1281-1302.
2. Hancock, B. C.; Zografi, G. Characteristics and Significance of the Amorphous State in Pharmaceutical Systems [Review]. J. Pharm. Sci. 1997, 86 (1), 1-12.
3. Leuner, C.; Dressman, J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50 (1), 47-60. (Pubitemid 30326688)
4. Yu, L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv. Drug Delivery Rev. 2001, 48 (1), 27-42.
5. Oberholtzer, E. R.; Brenner, G. S. Cefoxitin Sodium - Solution and Solid-State Chemical-Stability Studies. J. Pharm. Sci. 1979, 68 (7), 863-866.
6. Pikal, M. J.; Lukes, A. L.; Lang, J. E.; Gaines, K. Quantitative Crystallinity Determinations for Beta-Lactam Antibiotics by Solution Calorimetry - Correlations with Stability. J. Pharm. Sci. 1978, 67 (6), 767-772. (Pubitemid 8355230)
7. Andronis, V.; Zografi, G. Crystal nucleation and growth of indomethacin polymorphs from the amorphous state. J. Non -Cryst. Solids 2000, 271 (3), 236-248. (Pubitemid 30876406)
8. Hancock, B. C.; Zografi, G. The use of solution theories for predicting water vapor absorption by amorphous pharmaceutical solids: A test of the Flory-Huggins and Vrentas models. Pharm. Res. 1993, 10 (9), 1262-1267. (Pubitemid 23261823)
9. Andronis, V.; Yoshioka, M.; Zografi, G. Effects of sorbed water on the crystallization of indomethacin from the amorphous state. J. Pharm. Sci. 1997, 86 (3), 346-351. (Pubitemid 27113770)
10. Shamblin, S. L.; Zografi, G. The effects of absorbed water on the properties of amorphous mixtures containing sucrose. Pharm. Res. 1999, 16 (7), 1119-1124. (Pubitemid 29368163)
11. Ford, J. L. The Current Status of Solid Dispersions. Pharm. Acta HelV. 1986, 61, 69-88.
12. Saleki-Gerhardt, A.; Zografi, G. Nonisothermal And Isothermal Crystallization Of Sucrose From The Amorphous State. Pharm. Res. 1994, 11 (8), 1166-1173.
13. Taylor, L. S.; Langkilde, F. W.; Zografi, G. Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers. J. Pharm. Sci. 2001, 90 (7), 888-901. (Pubitemid 32645946)
14. Aso, Y.; Yoshioka, S.; Zhang, J.; Zografi, G. Effect of water on the molecular mobility of sucrose and poly(vinylpyrrolidone) in a colyophilized formulation as measured by C-13-NMR relaxation time. Chem. Pharm. Bull. 2002, 50 (6), 822-826. (Pubitemid 41694902)
15. Marsac, P. J.; Konno, H.; Rumondor, A. C. F.; Taylor, L. S. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water. Pharm. Res. 2008, 25 (3), 647-656.
16. Konno, H.; Taylor, L. S. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Pharm. Res. 2008, 25 (4), 969-978.
17. Marsac, P. J.; Rumondor, A. C. F.; Nivens, D. E.; Kestur, U. S.; Stanciu, L.; Taylor, L. S., Miscibility of Amorphous Dispersions of Felodipine and Poly(vinyl pyrrolidone). J. Pharm. Sci., in press.
18. Vasanthavada, M.; Tong, W. Q.; Joshi, Y.; Kislalioglu, M. S. Phase behavior of amorphous molecular dispersions - II: Role of hydrogen bonding in solid solubility and phase separation kinetics. Pharm. Res. 2005, 22 (3), 440-448.
19. Taylor, L. S.; Zografi, G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 1997, 14 (12), 1691-1698. (Pubitemid 28062912)
20. Wang, L. A.; Cui, F. D.; Hayase, T.; Sunada, H. Preparation and evaluation of solid dispersion for nitrendipine-Carbopol and nitrendipine-HPMCP systems using a twin screw extruder. Chem. Pharm. Bull. 2005, 53 (10), 1240-1245.
21. Marsac, P. J.; Konno, H.; Taylor, L. S. A comparison of the physical stability of amorphous felodipine and nifedipine systems. Pharm. Res. 2006, 23 (10), 2306-2316.
22. Lu, Q.; Zografi, G. Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid, and PVP. Pharm. Res. 1998, 15 (8), 1202-1206. (Pubitemid 28401710)
23. Six, K.; Murphy, J.; Weuts, I.; Craig, D. Q. M.; Verreck, G.; Peeters, J.; Brewster, M.; Van den Mooter, G. Identification of phase separation in solid dispersions of itraconazole and Eudragit (R) E100 using microthermal analysis. Pharm. Res. 2003, 20 (1), 135-138.
24. Marsac, P. J. Molecular Level Understanding of Polymer Induced Formation and Stabilization of Amorphous API; Purdue University: West Lafayette, 2007.
25. Chan, K. L. A.; Fleming, O. S.; Kazarian, S. G.; Vassou, D.; Chryssikos, G. D.; Gionis, V. Polymorphism and devitrification of nifedipine under controlled humidity: a combined FT-Raman, IR and Raman microscopic investigation. J. Raman Spectrosc. 2004, 35 (5), 353-359.
26. He, X. R.; Griesser, U. J.; Stowell, J. G.; Borchardt, T. B.; Byrn, S. R. Conformational color polymorphism and control of crystallization of 5-methyl-2-[(4-methy1-2-nitrophenyl)amino]-3-thiophenecarbonitrile. J. Pharm. Sci. 2001, 90 (3), 371-388.
27. Rumondor, A. C. F. The Effects of Moisture on Pharmaceutical Amorphous Solid Dispersion Systems; Purdue University: West Lafayette, 2009.
28. Shamblin, S. L.; Taylor, L. S.; Zografi, G. Mixing Behavior of Colyophilized Binary Systems. J. Pharm. Sci. 1998, 87 (6), 694-701. (Pubitemid 28268567)
29. Crowley, K. J.; Zografi, G. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions. J. Pharm. Sci. 2002, 91 (10), 2150-2165. (Pubitemid 35050700)
30. Di Martino, P.; Joiris, E.; Gobetto, R.; Masic, A.; Palmieri, G. F.; Martelli, S. Ketoprofen-poly(vinylpyrrolidone) physical interaction. J. Cryst. Growth 2004, 265 (1-2), 302-308.
31. Yalkowsky, S. H. Solubility and Solubilization in Aqueous Media; Oxford University Press: New York, NY, 1999.
32. Hoffman, J. D. Thermodynamic Driving Force In Nucleation And Growth Processes. J. Chem. Phys. 1958, 29 (5), 1192-1193.
33. Marsac, P. J.; Li, T.; Taylor, L. S. Estimation of Drug-Polymer Miscibility and Solubility in Amorphous Solid Dispersions Using Experimentally Determined Interaction Parameters. Pharm. Res. 2009, 26 (1), 139-151.
34. Marcolli, C.; Luo, B. P.; Peter, T. Mixing of the organic aerosol fractions: Liquids as the thermodynamically stable phases. J. Phys. Chem. A 2004, 108 (12), 2216-2224.
35. Flory, P. J. Principles of Polymer Chemistry; Cornell University Press: Ithaca, NY, 1953.
36. Zhang, J.; Zografi, G. Water vapor absorption into amorphous sucrose-poly(vinyl pyrrolidone) and trehalose-poly(vinyl pyrrolidone) mixtures. J. Pharm. Sci. 2001, 90 (9), 1375-1385. (Pubitemid 32867986)
37. Gregorowicz, J.; Luszczyk, M. Impact of water on the miscibility of DAB-dendr-(NH2)(64) and benzene. Macromolecules 2007, 40 (16), 5966-5972.
38. Zhang, J.; Zografi, G. The relationship between "BET"- and "Free volume"-derived parameters for water vapor absorption into amorphous solids. J. Pharm. Sci. 2000, 89 (8), 1063-1072.
39. Gupta, M. K.; Vanwert, A.; Bogner, R. H. Formation of physically stable amorphous drugs by milling with Neusilin. J. Pharm. Sci. 2003, 92 (3), 536-551.
40. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 14th ed.; Merck & Co., Inc.: Whitehouse Station, NJ, 2006.
41. Yalkowsky, S. H.; He, Y. Handbook of Aqueous Solubility Data; CRC Press: Boca Raton, 2003.
42. Tong, P.; Zografi, G. A study of amorphous molecular dispersions of indomethacin and its sodium salt. J. Pharm. Sci. 2001, 90 (12), 1991-2004. (Pubitemid 33144445)
43. Actins, A.; Arajs, R.; Belakovs, S.; Orola, L.; Veidis, M. V. The crystal and molecular structure of a polymorph and a pseudo-polymorph of droperidol. J. Chem. Crystallogr. 2008, 38 (3), 169-174.
44. Liang, L.; Zhu, N. J.; White, J.; Brown, C.; Klein-Stevens, C. L. A crystallographic and molecular modeling study of butyrophenones. J. Pharm. Sci. 1998, 87 (12), 1496-1501. (Pubitemid 28559630)
45. Blassi, P.; Schoubben, A.; Giovagnoli, S.; Perioli, L.; Ricci, M.; Rossi, C. Ketoprofen Poly(lactide-co-glycolide) Physical Interaction. AAPS Pharm. Sci. Tech. 2007, 8 (2), E1-E8.